Clinical Trials Directory

Trials / Completed

CompletedNCT00784511

Vitamin D, Glucose Control and Insulin Sensitivity in African-Americans

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Tufts University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

North American blacks tend to have low blood levels of vitamin D because pigmentation blocks vitamin D production in the skin. They also have higher rates of developing type 2 diabetes and higher rates of complications from the disease compared with whites. Although there is compelling evidence that adequate vitamin D may reduce the risk for type 2 diabetes in whites, recent evidence from a national survey demonstrated an association of vitamin D with diabetes in whites but not in blacks. However, the central hypothesis of this study is that providing enough supplemental vitamin D to blacks (raising their blood levels higher than that of most participants in the survey) will improve blood measures related to diabetes risk. The proposed study is a 12-week randomized, double-blind, placebo-controlled experiment designed to examine the effect of vitamin D supplementation (100 μg/d ) on insulin secretion, insulin sensitivity and glucose control in pre-diabetic black men and women aged 40 and older.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcholecalciferol4000 IU/d
OTHERmicrocrystalline cellulose1/d

Timeline

Start date
2008-07-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2008-11-04
Last updated
2014-11-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00784511. Inclusion in this directory is not an endorsement.